Event Type: The document intimates scheduled Analyst/Institutional Investor Meetings consisting of one-on-one and group meetings at three major investor conferences.
Schedule Details:
August 12, 2026: Emkay Confluence 2026 in Mumbai (In-person)
August 13, 2026: Equirus Annual India Conference 2026 in Mumbai (In-person)
August 18, 2026: Motilal Oswal 22nd Annual Global Investor Conference 2026 in Mumbai (In-person)
Regulatory Context: The intimation is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.
Contingency Note: The company explicitly states that the schedule may undergo change due to exigencies on the part of attendees or the Company, with any revisions to be communicated to the Stock Exchanges.
Management Participants: No specific management participants or their designations are disclosed in this intimation.
Presentation Materials: The document does not indicate whether any presentation, earnings deck, transcript, or recording will be made available.
UPSI Statement: The document does not contain any specific statement regarding unpublished price sensitive information (UPSI).
Additional Notes Section
Financial Data Disclosure: No financial data, performance figures, or guidance references are included in this regulatory filing.
Attachments: The document does not mention any attachments such as investor decks, conference schedules, or compliance letters.
Authentication: The communication is digitally signed by Dipti Khandelwal, Company Secretary and Compliance Officer (Membership No. F11340), with full digital signature details and timestamp (2026.08.04 14:55:49 +05'30').
